Literature DB >> 8224620

Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.

M Bergenfeldt1, K Ohlsson.   

Abstract

Whole-blood chemiluminescence and levels of leukocyte proteases and plasma protease inhibitors were studied in 43 patients with acute, generalized peritonitis. An almost three-fold increase in whole-blood chemiluminescence was found in acute peritonitis, which may indicate activation or "priming" of the leukocytes by blood-borne factors. High levels of leukocyte elastase and neutrophil proteinase 4(3) were found in plasma and peritoneal exudate. Patients with sepsis had higher plasma levels of both proteases than other patients. Large variations in the plasma levels among patients decreased their sensitivity as markers of infectious complications during the postoperative period. The plasma levels of the protease inhibitors followed three different patterns of reaction. The acute phase proteins alpha 1-proteinase inhibitor and C1-inactivator, increased during the first week of disease, to normalise later in its course. alpha 2-macroglobulin, antithrombin III and alpha 2-antiplasmin were all decreased from onset and normalised later in the course, while secretory leukocyte protease inhibitor showed a slow decrease throughout the course of disease. In peritonitis exudate, the levels of the main protease inhibitors, alpha 1-Proteinase Inhibitor and alpha 2-Macroglobulin, were decreased, probably due to complexation and subsequent elimination, as a part of the defense against liberated leukocyte proteases. The immunoreactive and especially functional levels of the protease inhibitors alpha 2-Antiplasmin, Antithrombin III and C1-Inactivator were also decreased in the exudate, indicating an increased turn-over of these proteins through activation of the cascade systems and/or break-down by leukocyte proteases. In contrast to the other inhibitors, secretory leukocyte protease inhibitor showed higher levels in exudate than in plasma, and unexpectedly high exudate/plasma-quotients were seen in cases with colonic perforations. Degradation of complement factor 3 (C3) and decreased "opsonic capacity" were found in exudate. The "opsonic capacity" could be correlated to the levels of leukocyte proteases in the exudate, which indicates that degradation of complement factor 3 may have been at least partly due to the action of leukocyte proteases. Further depletion of complement factors in exudates of long-standing peritonitis or abscesses may create a vicious circle of deficient opsonisation and clearance of bacteria, as earlier reported for chronic pleural exudates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224620     DOI: 10.1007/bf02806350

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  53 in total

Review 1.  Neutrophil activation by recombinant cytokines.

Authors:  M J Steinbeck; J A Roth
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

Review 2.  Imbalance between polymorphonuclear leukocyte proteases and antiproteases in chronic pyogenic infections and its relation to the proteolysis of complement component C3.

Authors:  S Suter
Journal:  Complement       Date:  1986

Review 3.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Characterization of two azurphil granule proteases with active-site homology to neutrophil elastase.

Authors:  C G Wilde; J L Snable; J E Griffith; R W Scott
Journal:  J Biol Chem       Date:  1990-02-05       Impact factor: 5.157

5.  Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids.

Authors:  H Tegner
Journal:  Acta Otolaryngol       Date:  1978 Mar-Apr       Impact factor: 1.494

6.  Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.

Authors:  M S Brower; P C Harpel
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

7.  Signs of neutrophil and eosinophil activation in adult respiratory distress syndrome.

Authors:  R Hällgren; T Borg; P Venge; J Modig
Journal:  Crit Care Med       Date:  1984-01       Impact factor: 7.598

8.  Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.

Authors:  P D Lew; R Zubler; P Vaudaux; J J Farquet; F A Waldvogel; P H Lambert
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

9.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Authors:  L A Smedly; M G Tonnesen; R A Sandhaus; C Haslett; L A Guthrie; R B Johnston; P M Henson; G S Worthen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Posttraumatic complications and inflammatory mediators.

Authors:  J K Nuytinck; J A Goris; H Redl; G Schlag; P J van Munster
Journal:  Arch Surg       Date:  1986-08
View more
  3 in total

1.  Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.

Authors:  M Bergenfeldt; M Nyström; M Bohe; C Lindström; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

2.  Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.

Authors:  R Berling; A Borgström; K Ohlsson
Journal:  Int J Pancreatol       Date:  1998-08

3.  IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.

Authors:  U Westin; E Lundberg; K Ohlsson
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.